Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of Cyclic Guanosine Monophosphate (cGMP) in Solid Tissues using Competitive Enzyme-Linked Immunosorbent Assay (ELISA).

Journal of visualized experiments : JoVE·2025
Same author

Nitrate as Warden of Nitric Oxide Homeostasis in Mammals.

Nutrients·2025
Same author

Sickle cell anaemia therapy in 2025.

British journal of haematology·2024
Same author

Hydroxyurea inhibits proliferation and stimulates apoptosis through inducible nitric oxide synthase in erythroid cells.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2024
Same author

Effects of low and high dietary nitrate intake on human saliva, plasma and skeletal muscle nitrate and nitrite concentrations and their functional consequences.

Free radical biology & medicine·2024
Same author

Skeletal Muscle, Skin, and Bone as Three Major Nitrate Reservoirs in Mammals: Chemiluminescence and <sup>15</sup>N-Tracer Studies in Yorkshire Pigs.

Nutrients·2024
Same journal

The lncRNA-m6A axis in cancer: a bidirectional regulatory network in tumor progression and therapeutic resistance.

Journal of translational medicine·2026
Same journal

Repurposing cepharanthine as a radiosensitizer in esophageal squamous cell carcinoma through dual metabolic intervention and direct targeting of p70s6K.

Journal of translational medicine·2026
Same journal

Cellular crosstalk and signaling networks in the rheumatoid arthritis synovial microenvironment.

Journal of translational medicine·2026
Same journal

Pilot spatial transcriptomics of dental pulpitis suggests immune-fibroblast profiling linked to reversibility.

Journal of translational medicine·2026
Same journal

Beyond semen analysis: in men with normal semen parameters telomere attrition and oxidative imbalance distinguish those fertile from those with infertility.

Journal of translational medicine·2026
Same journal

Dual-block HER2 assessment reveals clinically relevant intratumoral heterogeneity in gynecologic cancers: a single-center landscape analysis.

Journal of translational medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 16, 2026

Quantitative Immunofluorescence to Measure Global Localized Translation
09:13

Quantitative Immunofluorescence to Measure Global Localized Translation

Published on: August 22, 2017

Translational medicine--doing it backwards.

Robert B Nussenblatt1, Francesco M Marincola, Alan N Schechter

  • 1Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA. DrBob@nei.nih.gov

Journal of Translational Medicine
|February 6, 2010
PubMed
Summary
This summary is machine-generated.

Translational medicine requires scientists to adopt new discovery approaches. Current systems favor non-human models, hindering clinically relevant hypotheses and human pathophysiology research.

More Related Videos

Engineering of Human Blood-Induced Microglia-like Cells for Reverse-Translational Brain Research
06:12

Engineering of Human Blood-Induced Microglia-like Cells for Reverse-Translational Brain Research

Published on: September 6, 2024

Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems
06:18

Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems

Published on: April 26, 2019

Related Experiment Videos

Last Updated: Jun 16, 2026

Quantitative Immunofluorescence to Measure Global Localized Translation
09:13

Quantitative Immunofluorescence to Measure Global Localized Translation

Published on: August 22, 2017

Engineering of Human Blood-Induced Microglia-like Cells for Reverse-Translational Brain Research
06:12

Engineering of Human Blood-Induced Microglia-like Cells for Reverse-Translational Brain Research

Published on: September 6, 2024

Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems
06:18

Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems

Published on: April 26, 2019

Area of Science:

  • Biomedical Research
  • Translational Medicine

Background:

  • The current scientific paradigm struggles to translate basic research into clinical applications.
  • The dominant funding system prioritizes model systems over human-based research, impacting hypothesis generation.

Purpose of the Study:

  • To evaluate scientist readiness for translational medicine.
  • To critique the current hypothesis-driven research model in biomedical science.
  • To propose fundamental changes for effective translational medicine.

Main Methods:

  • Conceptual analysis of current research paradigms.
  • Critique of the biomedical funding system.
  • Discussion of the limitations in clinical study designs.

Main Results:

  • The hypothesis-driven model is ill-suited for translational medicine without clinically relevant hypotheses.
  • The funding system encourages research detached from human disease relevance.
  • This leads to insufficient rigor in hypothesis selection and limited scope in clinical studies.

Conclusions:

  • The current approach to translational medicine is illogical.
  • A fundamental shift in scientific approach and funding is necessary.
  • Prioritizing human pathophysiology and clinically relevant hypotheses is crucial for impactful translational medicine.